|
Volumn 25, Issue 1, 2002, Pages 57-62
|
Enhanced anti-B-cell tumor effects with anti-CD20 superantibody
a a a a |
Author keywords
Anti CD20; Antibody; Apoptosis; Immunotherapy; Tumor
|
Indexed keywords
B LYMPHOCYTE RECEPTOR;
CD20 ANTIGEN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD20;
UNCLASSIFIED DRUG;
ANTIBODY DETECTION;
ANTIBODY STRUCTURE;
ANTIGEN ANTIBODY COMPLEX;
APOPTOSIS;
ARTICLE;
B CELL LEUKEMIA;
CANCER IMMUNOTHERAPY;
CONTROLLED STUDY;
CROSS LINKING;
DIAGNOSTIC VALUE;
DRUG TARGETING;
HUMAN;
HUMAN CELL;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
TUMOR CELL;
TUMOR GROWTH;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIBODIES;
ANTIGENS, CD20;
APOPTOSIS;
HUMANS;
LYMPHOMA, B-CELL;
MICE;
MOLECULAR SEQUENCE DATA;
TUMOR CELLS, CULTURED;
|
EID: 0036138129
PISSN: 10538550
EISSN: None
Source Type: Journal
DOI: 10.1097/00002371-200201000-00006 Document Type: Article |
Times cited : (13)
|
References (13)
|